Listerine meeting postponed
This article was originally published in The Tan Sheet
Executive Summary
"Feedback" meeting on Pfizer's proposed changes to the OTC anticaries final monograph, originally slated for June 18, will be rescheduled within a month to give Division of OTC Drug Products more time to review relevant material, FDA says June 14. Meeting is part of Pfizer's efforts to amend monograph to allow for a mouthrinse combining essential oils, sodium fluoride (1"The Tan Sheet" June 10, 2002, p. 3)...You may also be interested in...
Listerine With Fluoride Proposed Six-Month Study To Be Reviewed By FDA
Pfizer Consumer Healthcare plans to conduct a six-month clinical study involving at least 300 subjects to determine whether adding .02% sodium fluoride to the company's Listerine mouthrinse affects the antiplaque/ antigingivitis effectiveness of the product
Mylan Weighs In On Coronavirus Drug Shortage Concerns
Hours before the US FDA confirmed the first drug shortage due to active pharmaceutical ingredient constraints because of the coronavirus situation in China, generics industry leader Mylan came under pressure about the potential impact on its business.
Eyes On Pricing As Zolgensma Moves Closer To Japan Market
Government advisory committee gives initial nod to what will become Japan’s most expensive single drug, but reimbursement pricing could come in for close scrutiny.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: